MD SB498 | 2019 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on February 4 2019 - 25% progression, died in chamber
Action: 2019-03-15 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 4 2019 - 25% progression, died in chamber
Action: 2019-03-15 - Unfavorable Report by Finance; Withdrawn
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring the Prescription Drug Monitoring Program to disclose prescription monitoring data, in accordance with certain regulations, to the medical director or the designee of the medical director of Medicaid managed care organizations for the purpose of complying with the Corrective Managed Care Program of the Maryland Medicaid Pharmacy Program or the standards developed by the Maryland Medicaid Opioid Drug Utilization Review Workgroup.
Title
Prescription Drug Monitoring Program - Disclosure of Data - Managed Care Organizations
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2019-03-15 | Senate | Unfavorable Report by Finance; Withdrawn |
| 2019-02-06 | Senate | Hearing 2/28 at 1:00 p.m. |
| 2019-02-04 | Senate | First Reading Finance |
Subjects
Committees and Commissions
Communications
Data
Disclosure
Drugs
Examinations
Federal Government
Health Occupations
Investigations and Inquiries
Law Enforcement
Licenses
Managed Care Organizations
Medical Assistance
Medical Treatments
Opioids
Patients
Pharmacists and Pharmacies
Physicians
Privacy
Public Health
Rules and Regulations
Subpoenas
Communications
Data
Disclosure
Drugs
Examinations
Federal Government
Health Occupations
Investigations and Inquiries
Law Enforcement
Licenses
Managed Care Organizations
Medical Assistance
Medical Treatments
Opioids
Patients
Pharmacists and Pharmacies
Physicians
Privacy
Public Health
Rules and Regulations
Subpoenas
